The Company undertakes businesses as follows: (1) Securities Brokerage Business, (2) Derivatives Brokerage Business, (3) Investment Banking Business, (4) Investment-Related Business, (5) Derivative Warrants Business, (6) Selling Agent Business, (7) Securities Borrowing and Lending Business, (8) Global Trading Business, (9) Bond Trading Business
IssuerFSS
UnderlyingCNBIO ETF
Full Underlying NameGLOBAL X CHINA BIOTECH ETF (2820)
Trading SessionDay Session
Conversion Ratio200:1
Outstanding DR (Units)21,440,000
Market Cap (M.Baht)32.59
First Trading Date09 Dec 2025
First Offering Price* (Baht)1.48
Par Value0
MarketSET
ISIN NumberTH0802120004
